Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain
Carmen Peral,1 Francisco Sánchez-Ballester,2 José M García-Mediero,3 Jaime Ramos,1 Javier Rejas1 1Health Economics & Outcomes Research Department, Pfizer, Alcobendas (Madrid), 2Department of Urology, Hospital General Universitario de Valencia, Valencia, 3Department of Urology, Hospital MD Anders...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Liburua |
| Argitaratua: |
Dove Medical Press,
2016-09-01T00:00:00Z.
|
| Gaiak: | |
| Sarrera elektronikoa: | Connect to this object online. |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Internet
Connect to this object online.3rd Floor Main Library
| Sailkapena: |
A1234.567 |
|---|---|
| Alea 1 | Eskuragarri |